FRE firebrick pharma limited

Ann: New agreement allows Nasodine launch in Philippines, page-12

  1. 155 Posts.
    lightbulb Created with Sketch. 127
    Thanks @gw85. I appreciate the positive feedback and great to hear that Nasodine is working well for you.
    As you would have seen on the Singapore packaging, currently Nasodine is not recommended for children under 12. However, I completely understand the need for something for younger kids, because they seem to be constantly sick with colds during winter months.
    Yes, in the past, we said we were considering clinical trials in children aged 6-11 (ASX release of 21 February 2023: "FRE files EU Paediatric Investigation Plan for Nasodine"). This was part of a European marketing approval application as a treatment for the common cold, which we were planning at the time. In Europe, you are required to submit a development plan for the product in children (Paediatric Investigation Plan or 'PIP') for the same indication. Suffice to say, the European application as a treatment for the common cold has not proceeded and those particular trials have not been proceeded.
    However, given our new commercial positioning as a nasal antiseptic, rather than a treatment for the common cold, we may have more flexibility in the future.

    PM

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.2¢
Change
-0.008(11.4%)
Mkt cap ! $13.92M
Open High Low Value Volume
6.9¢ 6.9¢ 6.2¢ $5.508K 86.81K

Buyers (Bids)

No. Vol. Price($)
1 7991 6.3¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 30292 1
View Market Depth
Last trade - 11.55am 26/06/2025 (20 minute delay) ?
FRE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.